Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lipoproteins and Cardiovascular Health
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the efficacy and safety of cholesterol-lowering treatments, particularly statins, in the prevention and management of cardiovascular diseases. It includes meta-analyses, clinical trials, guidelines, and genetic studies related to LDL cholesterol, atherosclerotic cardiovascular risk, hypercholesterolemia, and the role of C-reactive protein. The cluster also explores the impact of statins on various patient populations and their pleiotropic effects.
468
Works
IDs:OpenAlex
How has Lipoproteins and Cardiovascular Health's publication output changed over time?
ScholarIQpublication output · 1995–2019
Output grew200% over the shown period — from 1 works in 1995 to 3 in 2019.
1
1
1
2
1
2
1
1
1
3
1995199620032004200820132015201720182019
What are the most-cited papers on Lipoproteins and Cardiovascular Health?
ScholarIQmost cited works
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
François Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimón, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, ESC Scientific Document Group, Christian Mueller, Heinz Drexel, Victor Aboyans, Alberto Corsini, Wolfram Doehner, Michel Farnier, Bruna Gigante, Meral Kayıkçıoğlu, Goran Krstačić, Ekaterini Lambrinou, Basil S. Lewis, Josep Masip, Philippe Moulin, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Xavier Pintó, Lorenz Räber, Kausik K. Ray, Željko Reiner, Walter F. Riesen, Marco Roffi, Jean-Paul Schmid, Е. V. Shlyakhto, Iain A Simpson, Erik S.G. Stroes, Isabella Sudano, Alexandros D. Tselepis, Margus Viigimaa, Cécile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalović, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Е. V. Shlyakhto
European Heart Journal. 20199,055 CitationsOPEN ACCESS
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Anders Olsson, John J.V. McMurray, G Thorgeirsson, Christian Spaulding, Jim Slattery, Kalevi Pyörälà, Ole Færgeman, R. Scott Wright, Katherine M. Berg, Lars Wilhelmsen, T.R. Pedersen, T. A. Miettinen, HD White, John Kjekshus, Michael Gnant
The Lancet. 19948,491 Citations
General Cardiovascular Risk Profile for Use in Primary Care
Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina, Philip A. Wolf, Mark R. Cobain, Joseph M. Massaro, William B. Kannel
Circulation. 20087,541 CitationsOPEN ACCESS
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, Jean L. Rouleau, John D. Rutherford, Thomas Cole, Lisa Brown, J. Wayne Warnica, J. Malcolm O. Arnold, Chuan‐Chuan Wun, Barry R. Davis, Eugene Braunwald
New England Journal of Medicine. 19967,496 CitationsOPEN ACCESS
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford, Christopher Isles, A R Lorimer, Peter W. Macfarlane, James H. McKillop, Christopher J. Packard
New England Journal of Medicine. 19957,486 CitationsOPEN ACCESS
Where is Lipoproteins and Cardiovascular Health research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Lipoproteins and Cardiovascular Health is open access?
ScholarIQopen access share
80%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
7%
Bronze
73%
Closed
20%
Related on ScholarIQ
Diagnosis and Management of the Metabolic Syndrome
Paper
Prediction of Coronary Heart Disease Using Risk Factor Categories
Paper
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Paper
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
Paper
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Paper
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Paper